Valuation FDC Limited

Stocks

Delayed Bombay S.E. Other stock markets 03:02:06 2026-07-06 EDT			5-day change	1st Jan Change
429.95 ^INR	-0.76%		+2.30%	+1.57%

05-27	FDC Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
05-27	F D C March-quarter consol profit 1.03 billion rupees	RE

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	33,502	48,229	43,367	42,564	69,121	64,196
Change	-	43.96%	-10.08%	-1.85%	62.39%	-7.13%
Enterprise Value (EV) ¹	28,332	42,822	38,304	38,036	64,572	59,046
Change	-	51.14%	-10.55%	-0.7%	69.77%	-8.56%
P/E	14.1x	16.1x	20x	22x	22.8x	24.1x
PBR	2.17x	2.78x	2.22x	2.15x	3.3x	2.81x
PEG	-	0.6x	-0.7x	-2.46x	0.4x	-2x
Capitalization / Revenue	2.49x	3.62x	2.84x	2.39x	3.56x	3.05x
EV / Revenue	2.11x	3.21x	2.51x	2.13x	3.32x	2.8x
EV / EBITDA	9.5x	13.1x	15.6x	15.7x	19.6x	18.7x
EV / EBIT	10.6x	14.5x	17.7x	17.9x	21.6x	21.8x
EV / FCF	18.6x	32.7x	159x	349x	76.6x	27.8x
FCF Yield	5.39%	3.05%	0.63%	0.29%	1.31%	3.6%
Dividend per Share ²	0.8	-	-	-	-	5
Rate of return	0.41%	-	-	-	-	1.27%
EPS ²	13.94	17.73	12.82	11.67	18.59	16.39
Distribution rate	5.74%	-	-	-	-	30.5%
Net sales ¹	13,442	13,332	15,279	17,838	19,429	21,081
EBITDA ¹	2,981	3,267	2,461	2,424	3,297	3,152
EBIT ¹	2,673	2,962	2,164	2,120	2,986	2,711
Net income ¹	2,399	3,013	2,164	1,940	3,052	2,668
Net Debt ¹	-5,170	-5,407	-5,063	-4,529	-4,549	-5,150
Reference price ²	195.95	285.70	256.90	256.55	424.55	394.30
Nbr of stocks (in thousands)	170,973	168,810	168,810	165,910	162,810	162,810
Announcement Date	9/8/20	9/6/21	8/29/22	9/4/23	9/3/24	8/29/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
FDC LIMITED	-	-	-	-	741M
ELI LILLY AND COMPANY	35.49x	12.89x	26.26x	0.56%	1,082B
JOHNSON & JOHNSON	28.11x	6.46x	17.57x	2.03%	633B
ABBVIE INC.	32.2x	7.69x	15.73x	2.65%	461B
ROCHE HOLDING AG	18.15x	4.51x	11.08x	2.94%	338B
ASTRAZENECA PLC	24.06x	5.03x	14.1x	1.73%	299B
NOVARTIS AG	22.19x	5.69x	13.74x	2.76%	291B
NOVO NORDISK A/S	14.43x	5.37x	11.03x	3.47%	222B
AMGEN INC.	24.39x	6.45x	11.36x	2.7%	202B
GILEAD SCIENCES, INC.	-46.87x	5.66x	31.47x	2.47%	163B
Average	16.90x	6.64x	16.92x	2.37%	369.31B
Weighted average by Cap.	24.74x	8.04x	18.59x	1.94%